The PDZ protein SCRIB regulates sodium/iodide symporter (NIS) expression at the basolateral plasma membrane
- PMID: 34196428
- DOI: 10.1096/fj.202100303R
The PDZ protein SCRIB regulates sodium/iodide symporter (NIS) expression at the basolateral plasma membrane
Abstract
The sodium/iodide symporter (NIS) expresses at the basolateral plasma membrane of the thyroid follicular cell and mediates iodide accumulation required for normal thyroid hormonogenesis. Loss-of-function NIS variants cause congenital hypothyroidism due to impaired iodide accumulation in thyroid follicular cells underscoring the significance of NIS for thyroid physiology. Here we report novel findings derived from the thorough characterization of the nonsense NIS mutant p.R636* NIS-leading to a truncated protein missing the last eight amino acids-identified in twins with congenital hypothyroidism. R636* NIS is severely mislocalized into intracellular vesicular compartments due to the lack of a conserved carboxy-terminal type 1 PDZ-binding motif. As a result, R636* NIS is barely targeted to the plasma membrane and therefore iodide transport is reduced. Deletion of the PDZ-binding motif causes NIS accumulation into late endosomes and lysosomes. Using PDZ domain arrays, we revealed that the PDZ-domain containing protein SCRIB binds to the carboxy-terminus of NIS by a PDZ-PDZ interaction. Furthermore, in CRISPR/Cas9-based SCRIB deficient cells, NIS expression at the basolateral plasma membrane is compromised, leading to NIS localization into intracellular vesicular compartments. We conclude that the PDZ-binding motif is a plasma membrane retention signal that participates in the polarized expression of NIS by selectively interacting with the PDZ-domain containing protein SCRIB, thus retaining the transporter at the basolateral plasma membrane. Our data provide insights into the molecular mechanisms that regulate NIS expression at the plasma membrane, a topic of great interest in the thyroid cancer field considering the relevance of NIS-mediated radioactive iodide therapy for differentiated thyroid carcinoma.
Keywords: PDZ domain-containing protein SCRIB; PDZ-binding motif; dyshormonogenic congenital hypothyroidism; iodide transport defect; sodium/iodide symporter (NIS).
© 2021 Federation of American Societies for Experimental Biology.
Similar articles
-
An Intramolecular Ionic Interaction Linking Defective Sodium/Iodide Symporter Transport to the Plasma Membrane and Dyshormonogenic Congenital Hypothyroidism.Thyroid. 2022 Jan;32(1):19-27. doi: 10.1089/thy.2021.0344. Epub 2021 Dec 24. Thyroid. 2022. PMID: 34726525
-
A Carboxy-Terminal Monoleucine-Based Motif Participates in the Basolateral Targeting of the Na+/I- Symporter.Endocrinology. 2019 Jan 1;160(1):156-168. doi: 10.1210/en.2018-00603. Endocrinology. 2019. PMID: 30496374 Free PMC article.
-
A Novel SLC5A5 Variant Reveals the Crucial Role of Kinesin Light Chain 2 in Thyroid Hormonogenesis.J Clin Endocrinol Metab. 2021 Jun 16;106(7):1867-1881. doi: 10.1210/clinem/dgab283. J Clin Endocrinol Metab. 2021. PMID: 33912899 Free PMC article.
-
Iodide handling disorders (NIS, TPO, TG, IYD).Best Pract Res Clin Endocrinol Metab. 2017 Mar;31(2):195-212. doi: 10.1016/j.beem.2017.03.006. Epub 2017 Apr 4. Best Pract Res Clin Endocrinol Metab. 2017. PMID: 28648508 Review.
-
The sodium/iodide symporter: state of the art of its molecular characterization.Biochim Biophys Acta. 2014 Jan;1838(1 Pt B):244-53. doi: 10.1016/j.bbamem.2013.08.013. Epub 2013 Aug 27. Biochim Biophys Acta. 2014. PMID: 23988430 Review.
Cited by
-
Combined Vorinostat and Chloroquine Inhibit Sodium-Iodide Symporter Endocytosis and Enhance Radionuclide Uptake In Vivo.Clin Cancer Res. 2024 Apr 1;30(7):1352-1366. doi: 10.1158/1078-0432.CCR-23-2043. Clin Cancer Res. 2024. PMID: 37921808 Free PMC article.
-
Advances in the molecular mechanism and targeted therapy of radioactive-iodine refractory differentiated thyroid cancer.Med Oncol. 2023 Jul 31;40(9):258. doi: 10.1007/s12032-023-02098-3. Med Oncol. 2023. PMID: 37524925 Review.
-
The master role of polarized NIS expression in regulating iodine metabolism in the human body.Arch Endocrinol Metab. 2023 Mar 10;67(2):256-261. doi: 10.20945/2359-3997000000583. Arch Endocrinol Metab. 2023. PMID: 36913678 Free PMC article.
-
Targeted Next-Generation Sequencing of Congenital Hypothyroidism-Causative Genes Reveals Unexpected Thyroglobulin Gene Variants in Patients with Iodide Transport Defect.Int J Mol Sci. 2022 Aug 17;23(16):9251. doi: 10.3390/ijms23169251. Int J Mol Sci. 2022. PMID: 36012511 Free PMC article.
-
Silent but Not Harmless: A Synonymous SLC5A5 Gene Variant Leading to Dyshormonogenic Congenital Hypothyroidism.Front Endocrinol (Lausanne). 2022 May 4;13:868891. doi: 10.3389/fendo.2022.868891. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35600585 Free PMC article.
References
REFERENCES
-
- Nicola JP, Carrasco N, Amzel LM. Physiological sodium concentrations enhance the iodide affinity of the Na+/I- symporter. Nat Commun. 2014;5:3948.
-
- De la Vieja A, Riesco-Eizaguirre G. Radio-Iodide treatment: from molecular aspects to the clinical view. Cancers (Basel). 2021;13:995.
-
- Martín M, Geysels RC, Peyret V, Bernal Barquero CE, Masini-Repiso AM, Nicola JP. Implications of Na+/I- symporter transport to the plasma membrane for thyroid hormonogenesis and radioiodide therapy. J Endoc Soc. 2019;3:222-234.
-
- Ravera S, Reyna-Neyra A, Ferrandino G, Amzel LM, Carrasco N. The Sodium/Iodide Symporter (NIS): molecular physiology and preclinical and clinical applications. Annu Rev Physiol. 2017;79:261-289.
-
- Martín M, Modenutti CP, Gil Rosas ML, et al. A Novel SLC5A5 variant reveals the crucial role of kinesin light chain 2 in thyroid hormonogenesis. J Clin Endocrinol Metab. 2021. https://doi.org/10.1210/clinem/dgab283
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
